New Zealand vs United States: Proportion of isolates with resistance to azithromycin reported to
New Zealand
6.5
in 2020
United States
5.8
in 2020
New Zealand rank
24th
United States rank
26th
Proportion of isolates with resistance to azithromycin reported to over time
- New Zealand
- United States
How they compare
New Zealand currently reports 6.5 against 5.8 in United States, a difference of 0.7.
That makes New Zealand's figure about 1.1 times United States's.
The two have swapped places 1 time across 6 shared years of data; in 2013 it was United States ahead.
New Zealand ranks 24th and United States ranks 26th of 47 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | United States | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.52 | 2.71 | 1.8 | New Zealand |
| 2020s | 6.5 | 5.8 | 0.7 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with resistance to azithromycin reported to, New Zealand or United States?
- New Zealand, at 6.5 against 5.8 in United States as of 2020.
- What is the difference in proportion of isolates with resistance to azithromycin reported to between New Zealand and United States?
- 0.7, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and United States?
- 6 years are reported by both, from 2013 to 2020.
- How do New Zealand and United States rank globally for proportion of isolates with resistance to azithromycin reported to?
- New Zealand ranks 24th and United States ranks 26th of 47 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.